Landscape Capital Management L.L.C. Buys 15,055 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Landscape Capital Management L.L.C. raised its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 102.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,775 shares of the company's stock after purchasing an additional 15,055 shares during the quarter. Landscape Capital Management L.L.C.'s holdings in Option Care Health were worth $691,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. increased its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC lifted its position in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares in the last quarter. Quarry LP boosted its stake in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after buying an additional 2,628 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after acquiring an additional 681 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

OPCH has been the topic of several analyst reports. JMP Securities reiterated a "market outperform" rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Barrington Research boosted their price target on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Remove Ads

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

Shares of OPCH traded down $2.14 during mid-day trading on Friday, hitting $31.55. 5,341,789 shares of the company's stock were exchanged, compared to its average volume of 1,774,881. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.18 billion, a price-to-earnings ratio of 26.51, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The stock's 50-day simple moving average is $33.24 and its 200-day simple moving average is $28.60. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.